Brief: Aroa Biosurgery Says Guidance Reduced For FY24
30/01/2024 24:52
Jan 30 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* GUIDANCE REDUCED TO NZ$67-70 MILLION TOTAL REVENUE FOR
FY24
* GUIDANCE REDUCED TO NORMALISED EBITDA LOSS OF NZ$1-3
MILLION FOR
FY24
Source text for Eikon: ID:nASX1DBQs4
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million